Recent Finacing
Recent Raise
Ankyra Therapeutics develops intratumoral cytokine-based cancer therapies using a platform forming an extended drug depot to prolong local immune activation, reduce systemic toxicity, and advance ANK-101 into Phase I.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Ankyra.
